Envision Pharma Group’s Post

Thrilled to have attended the SCOPE conference alongside my Daiichi Sankyo, Inc. colleagues Starr Vang, Laura Naranjo, Kristine Koontz, PhD, MBA, Susie Campos, Mohammad F., Jehan Poco, and Kevin Douglass - a fantastic experience of collaboration and shared knowledge! Explored groundbreaking discussions on patient-centric trial design, highlighting the pivotal role of prioritizing the patient experience in shaping future trials. Discussed effective approaches to streamline site activation and start-up processes, fostering efficiency in the clinical trial journey. Delved into strategies for enhancing clinical trial diversity, emphasizing inclusivity for more robust and representative outcomes. Exciting times ahead in revolutionizing the future of clinical trials! #SCOPE2024 #ClinicalTrials #PatientCentricity #DiversityInResearch #Innovation

Imagine this: You, surrounded by the brightest minds in digital health, exploring the forefront of therapeutic innovation, and gaining insights that could change the healthcare landscape forever. Sounds like a plan, right? Join us for the 7th Annual #DTxWest Summit next month from February 21 - 23 at the W Hollywood Hotel in sunny 🌅 Los Angeles, CA. What to expect? 🤔 ➡ A sit down and open Q&A with the FDA addressing their plans for digital healthcare in 2024 🎤 ➡ Practicing clinicians coming together to take the stage and address how we can successfully utilize DTx in the clinic 🏥 ➡ 5 Major Payer organisations coming together to lay down the law on how to get your digital product reimbursed. Find out what they really want to see! 💰 ➡ 4 hands on workshops carefully crafted to teach all on: Product Development, Routes to Market, AI in Healthcare and the DTx basics. 🛣 ➡ Novo Nordisk, Astellas, Bayer, Takeda and Nestle to discuss 'The Power of Pharma in Digital Therapeutics' 🔬 ➡ Real life digital investors to teach the basics on how to get your business funded in today's healthcare climate 📈 ......and a whole lot more! Register your place before the Final Early-Bird 🐦 offer ends NEXT WEEK, January 26th, so act fast. Register: www.dtxwest.com/register

Are you attending today’s Biospain event in Barcelona? Veristat is on-site and would love to say hello! Getting through the clinical development process is full of challenges. Our experts can help you break through barriers to get from idea to therapy approval and commercialization faster. Tomorrow, our European VP, Montserrat Barcelo Riera, MD, will share her knowledge during the Plenary Session: 'The Patient Voice as a Starting and Ending Point for the Development of New Innovative Healthcare Solutions' > https://bit.ly/3PPCKou #clinicaldevelopment #healthcaresolutions

A fascinating couple of days LSX in London. There was no shortage of insight at the intersection of MedTech, BioTech and HealthTech for digital health.  It was great to hear from speakers from Pharma like Gregoire Guillet from Servier, Beth Wolff from Lundbeck, Dominic James from MSD and Ventsislav Dobrev from our partner Ypsomed AG talking about the challenges and opportunities that Digital Health presents. Great insights too on the Medtech side from speakers like Thomas Hummel from Fresenius Kabi and Aneta Gawlowska from Medtronic. Key takeaways for me include:  ✅ Everyone is still searching for the right Digital Health business models that are sustainable, scalable and ideally independent of the core medical device or drug revenue ✅ The fragmented healthcare ecosystem means that there are a lot of friction points that slow adoption; partnering across the ecosystem will be a key part of everyone's future strategy ✅ Start small but plan to be able to scale fast - platform strategies will be essential Thanks all for a great event!

The past few years have really put the pharma industry to the test, haven't they? From the hurdles in clinical trial recruitment to the struggle with retention rates, it's been a rollercoaster ride. But amidst these challenges, there've been many who have not only pushed through the hurdles, but gone on to innovate. Partnering with many of these organizations has been nothing short of inspiring. They tackle tough times head-on and aren't afraid to venture into uncharted territory for the sake of progress.   So, you can imagine my pride in announcing our joint nomination with Moderna for not just one, but two categories at the upcoming Citeline awards:   🏆Clinical Partnership of the Year 👩💻Best Patient-facing Technology Initiative   It's a humbling recognition of the strides we've made together in revolutionizing clinical research.   This nomination speaks volumes about our shared commitment to prioritizing the patient experience in every aspect of our work. We've poured our hearts into crafting solutions that not only meet but exceed the evolving needs of patients and trial stakeholders alike.   I can't wait to raise a toast to all the incredible nominees and colleagues at the awards. Here's to innovation, patient experience, and the power of collaboration!   #ProofPilot #ClinicalTrials #Innovation #PatientExperience #AwardNomination

Join us at the upcoming DPHARM Summit in Boston from September 20-22!  Connect with our experts Denisa McKnight and Francesca Properzi, and dive deep into the world of clinical innovation.  We'll explore cutting-edge trends like digital maturity, participant experiences, and the invaluable voice of customers – all fuelling transformative clinical trial strategies. Don't miss out!  Meet you there and let's elevate your clinical game together!  #DecentralizedClinicalTrials #DPHARMSummit  

🌟 Thrilled to unveil a stellar Panel discussion at the #Fierce50Gala! 🌟 Join us for an engaging panel discussion ( Panel Discussion: Beyond the Status Quo: Insights from the Fierce 50) featuring a selection of this year's esteemed Fierce 50 honorees, each involved in reshaping healthcare and biopharma. They'll explain why settling for the status quo isn't an option and dive into the challenges and bright spots in these industries. They'll also share the valuable lessons they've learned from their experiences and discuss the biggest opportunities in the year ahead. Save the date - December 5, 2023, and join us at the Edison Ballroom in New York City for this extraordinary discussion. REGISTER NOW➡️: https://ow.ly/U6J250Q4LbZ 🗣️ Moderated by the exceptional Ayla Ellison, this session will feature insights and expertise from some of the most influential figures in healthcare and life sciences: 🔹 Jesse Ehrenfeld MD MPH - American Medical Association 🔹 Melinda Richter - Johnson & Johnson Innovation - JLABS. 🔹 Joseph Betancourt - The Commonwealth Fund. 🔹 Josh Trautwein - About Fresh. 🔹 James R. Downing, M.D. - St. Jude Children's Research Hospital. This powerhouse panel will explore groundbreaking ideas and game-changing strategies that will shape the future of healthcare and life sciences. Don't miss this unique opportunity to gain insights from the Fierce 50 leaders who are redefining the industry. See you there! 🗓️ #Fierce50Gala #Fierce50 #WeAreFierce #LifeSciences #Healthcare #Panel #Innovation #LifeSciences #ThoughtLeadership #NetworkingOpportunity #GalaEvent

On November 16, 2023, an important event on "Partnering and Business Models in Precision Medicine" will be presented by Johnson & Johnson Innovation’s Science & Partnering Forum. Why does precision medicine matter? 🔍 Discover how it can revolutionize healthcare by eliminating trial-and-error practices, saving costs, and improving patient lives. Some key speakers worth mentioning: - Gabriele Alegri, Head Global Commercial Strategy Precision Medicine, Johnson & Johnson - Elena Fernandez Kleinlein Fernandez-Kleinlein, Head of JLABS EMEA, Johnson & Johnson Innovation - Dianne Baunbaek, Diagnostics Lead, Johnson & Johnson ...and many more! ✨ Curious? Full agenda & panel details here: https://buff.ly/46qLDe1 Don't miss this opportunity to gain insights into the future of precision medicine. Register now and be part of the conversation. #PrecisionMedicine #Innovation #Healthcare #JNJInnovation #UtrechtInc #Johnson&Johnson

Future means possibilities, no matter what challenges we are facing. On a regular basis BioVentureHub company representatives, who are interested in Clinical Trials, meet in the BVH Clinical Trial Network. The aim is to develop, share, and apply knowledge through open discussions about challenges and interests identified by these representatives. Last week, Emma Larsson and Lisa Snäll from Gothia Forum Västra Götalandsregionen supported the BVH network discussion by providing an overview and excellent examples of the support they offer to the clinical trial community. The next agenda topic was a fascinating discussion about "Decentralised clinical trials", also known as virtual, remote, or digital clinical trials. This discussion received strong support from Marcus Wajngarten and Linda Zaragoza from AstraZeneca, Digital Health, who have extensive experience working with this approach from various perspectives. The session included sharing opportunities, risks to consider, valuable advice, support materials, and contacts related to the topic. It provided valuable insights, networking opportunities, and reflections on how both small and large companies, as well as public providers, must adapt, drive, and collaborate for the successful implementation of Decentralized clinical trials. Thanks to all involved for sharing. Looking forward to next time!   Pernilla Isberg, Monica Hjalmar, Hanne Evenbratt, Andreas Bringman, Oskar Sigfridson, Ahmed El Rhali, Fredrik Frick, PhD, Stefan Pierrou Anna Sjöblom-Hallén, Johanna Nilsson, PhD Robert Börjes   #BVHevent #Clinicaltrials #DareToShare #LifeScience #Growing #Innovation #Together #DigitalHealth